Short answer
MERIT MEDICAL SYSTEMS INC (MMSI) filed an 8-K current report with the SEC on February 24, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q-period earnings release and conference call materials filed as Exhibits 99.1 (press release) and 99.2 (presentation).
MERIT MEDICAL SYSTEMS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q-period earnings release and conference call materials filed as Exhibits 99.1 (press release) and 99.2 (presentation)
- MMSI reports both GAAP and non-GAAP results; reconciliations included in exhibits: key for evaluating true operating performance
- No forward-looking GAAP guidance provided (except revenue) due to unpredictable M&A costs, amortization, stock comp, and litigation expenses
- Excluded non-GAAP items include acquisition costs, intangible amortization, severance, performance stock comp, and litigation settlements: all can be material
Item 7.01 · Regulation FD Disclosure
- Q4 and full-year 2025 earnings call scheduled February 24, 2026
- Slide presentation (Exhibit 99.2) available on MMSI website alongside live webcast: key source for financial details
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MERIT MEDICAL SYSTEMS INC 8-K filings
Get the next MMSI 8-K as it lands
Follow MMSI for push alerts, or ask the research agent what this filing means.